logo-loader
viewFutura Medical PLC

Futura Medical kicks off process for its ED gel to be approved as medical device

Futura Medical PLC's (LON:FUM) Ken James tells Proactive London's Andrew Scott they've held positive initial discussions with EU regulators as it confirmed it will seek to have its erectile dysfunction (ED) gel approved as a medical device rather than a drug.

The decision to develop the gel as a device follows last year's read-out from the FM57 phase III clinical trial.

Quick facts: Futura Medical PLC

Price: 15.155 GBX

AIM:FUM
Market: AIM
Market Cap: £37.22 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical gets set to begin formal approval steps for erectile...

Futura Medical PLC’s (LON:FUR) James Barder talks to Proactive London’s Katie Pilbeam about the highlights in their half-year report which includes the latest on MED3000 - a topical treatment for Erectile Dysfunction. Proceedings have begun for formal approval of the drug to be approved as a...

5 days, 23 hours ago

2 min read